Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000433622 | SCV000516765 | likely pathogenic | not provided | 2023-08-26 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 23559409, 25726036, 27596865, 28621010, 29121203, 26260382, 29145603, 28973083, 29127259, 33875766, 31844813, 31216405, 32165824, 32604935, 34354814, 33323469, 34216551) |
Labcorp Genetics |
RCV000653250 | SCV000775126 | pathogenic | Asphyxiating thoracic dystrophy 5; Senior-Loken syndrome 8 | 2023-09-27 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 127158). This missense change has been observed in individual(s) with nephronophthisis (PMID: 23559409, 25726036, 27596865, 28621010). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. This variant is present in population databases (rs79436363, gnomAD 0.03%). This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 1178 of the WDR19 protein (p.Arg1178Gln). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on WDR19 protein function. For these reasons, this variant has been classified as Pathogenic. |
Rare Disease Group, |
RCV000754960 | SCV000788386 | uncertain significance | Cranioectodermal dysplasia | 2018-05-01 | criteria provided, single submitter | research | |
Eurofins Ntd Llc |
RCV000433622 | SCV000860737 | pathogenic | not provided | 2018-04-24 | criteria provided, single submitter | clinical testing | |
Department Of Genetics, |
RCV000115014 | SCV000891658 | uncertain significance | Senior-Loken syndrome 8 | 2017-12-30 | criteria provided, single submitter | curation | |
Baylor Genetics | RCV000850617 | SCV000992850 | pathogenic | Nephronophthisis 13; Senior-Loken syndrome 8 | 2017-12-31 | criteria provided, single submitter | clinical testing | |
Institute of Vision Research, |
RCV001262101 | SCV001371860 | likely pathogenic | Leber congenital amaurosis | 2020-07-09 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000115014 | SCV000148923 | pathogenic | Senior-Loken syndrome 8 | 2013-08-01 | no assertion criteria provided | literature only | |
OMIM | RCV003224149 | SCV003920719 | pathogenic | Nephronophthisis 13 | 2013-08-01 | no assertion criteria provided | literature only | |
OMIM | RCV003224150 | SCV003920720 | pathogenic | Cranioectodermal dysplasia 4 | 2013-08-01 | no assertion criteria provided | literature only |